0000899243-20-030389.txt : 20201104
0000899243-20-030389.hdr.sgml : 20201104
20201104163700
ACCESSION NUMBER: 0000899243-20-030389
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201103
FILED AS OF DATE: 20201104
DATE AS OF CHANGE: 20201104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIOTECH TARGET N V
CENTRAL INDEX KEY: 0001259870
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35986
FILM NUMBER: 201287213
MAIL ADDRESS:
STREET 1: ARA HILL TOP BUILDING, UNIT A-5
STREET 2: PLETTERIJWEG OOST 1, CURACAO
CITY: WILLEMSTAD
STATE: P8
ZIP: 000000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BB BIOTECH AG
CENTRAL INDEX KEY: 0000924223
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35986
FILM NUMBER: 201287214
BUSINESS ADDRESS:
STREET 1: SCHWERTSTRASSE 6
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: 8200
BUSINESS PHONE: 411724 59 59
MAIL ADDRESS:
STREET 1: SCHWERTSTRASSE 6
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: 8200
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Esperion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001434868
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3891 RANCHERO DRIVE, SUITE 150
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
BUSINESS PHONE: 734-887-3903
MAIL ADDRESS:
STREET 1: 3891 RANCHERO DRIVE, SUITE 150
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
FORMER COMPANY:
FORMER CONFORMED NAME: HDL THERAPEUTICS INC
DATE OF NAME CHANGE: 20080513
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-03
0
0001434868
Esperion Therapeutics, Inc.
ESPR
0001259870
BIOTECH TARGET N V
ARA HILL TOP BUILDING, UNIT A-5,
PLETTERIJWEG OOST 1
CURACAO
P8
00000
NETHERLANDS ANTILLES
0
0
1
0
0000924223
BB BIOTECH AG
SCHWERTSTRASSE 6
SCHAFFHAUSEN
V8
CH-8200
SWITZERLAND
0
0
1
0
Common Stock
2020-11-03
4
P
0
200000
25.3106
A
3947964
D
Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Esperion Therapeutics, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.
/s/ Ivo Betschart
2020-11-04